1. Home
  2. XERS vs RYI Comparison

XERS vs RYI Comparison

Compare XERS & RYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • RYI
  • Stock Information
  • Founded
  • XERS 2005
  • RYI 1842
  • Country
  • XERS United States
  • RYI United States
  • Employees
  • XERS N/A
  • RYI N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • RYI Metal Fabrications
  • Sector
  • XERS Health Care
  • RYI Industrials
  • Exchange
  • XERS Nasdaq
  • RYI Nasdaq
  • Market Cap
  • XERS 628.7M
  • RYI 699.3M
  • IPO Year
  • XERS 2018
  • RYI N/A
  • Fundamental
  • Price
  • XERS $4.51
  • RYI $19.18
  • Analyst Decision
  • XERS Strong Buy
  • RYI Hold
  • Analyst Count
  • XERS 6
  • RYI 1
  • Target Price
  • XERS $6.25
  • RYI $25.00
  • AVG Volume (30 Days)
  • XERS 2.1M
  • RYI 192.2K
  • Earning Date
  • XERS 08-07-2025
  • RYI 07-29-2025
  • Dividend Yield
  • XERS N/A
  • RYI 3.86%
  • EPS Growth
  • XERS N/A
  • RYI N/A
  • EPS
  • XERS N/A
  • RYI N/A
  • Revenue
  • XERS $222,551,000.00
  • RYI $4,495,200,000.00
  • Revenue This Year
  • XERS $35.03
  • RYI $0.35
  • Revenue Next Year
  • XERS $18.31
  • RYI $3.40
  • P/E Ratio
  • XERS N/A
  • RYI N/A
  • Revenue Growth
  • XERS 29.88
  • RYI N/A
  • 52 Week Low
  • XERS $2.03
  • RYI $17.18
  • 52 Week High
  • XERS $6.07
  • RYI $27.41
  • Technical
  • Relative Strength Index (RSI)
  • XERS 46.97
  • RYI 34.61
  • Support Level
  • XERS $4.30
  • RYI $20.27
  • Resistance Level
  • XERS $4.79
  • RYI $21.34
  • Average True Range (ATR)
  • XERS 0.23
  • RYI 0.77
  • MACD
  • XERS -0.01
  • RYI -0.18
  • Stochastic Oscillator
  • XERS 25.93
  • RYI 0.00

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

Share on Social Networks: